Central Ghrelin Resistance from Chronic Stress Permits Overconsolidation of Fear Memory in Rats
Background
The role of the hormone ghrelin in processing aversive experiences is controversial, with conflicting studies suggesting it can both enhance and inhibit aversion. This paradoxical effect creates a gap in understanding how metabolic signals influence emotional learning and memory, particularly in the context of stress-related disorders like PTSD where fear memory becomes dysregulated. The current research aimed to reconcile these contradictory findings by investigating how ghrelin signaling, specifically within the amygdala, modulates the acquisition and consolidation of fearful memories under both normal and chronic stress conditions, proposing a novel mechanism of 'metabolic resistance' in the brain.
Study Design
This study was performed in rats. Endogenous acyl-ghrelin and corticosterone levels were measured using enzyme-linked immunosorbent assay (ELISA) at various time points around an auditory fear learning protocol. The researchers used both systemic and direct intra-amygdala pharmacological manipulations to agonize the ghrelin receptor. They assessed several aversive and appetitive behaviors to isolate the effects on fear. To visualize ghrelin's site of action, they used biotin-labeled ghrelin to map binding sites in coronal brain sections of the amygdala, comparing unstressed rats to those exposed to chronic stress.
Results
In unstressed rats, endogenous peripheral acyl-ghrelin robustly inhibits the consolidation of fear memories through its action in the amygdala. Higher levels of ghrelin after fear learning were directly associated with weaker long-term fear memories. Pharmacological agonism of the ghrelin receptor during the memory consolidation window successfully reduced fear memory strength, an effect independent of changes in appetite. Critically, this protective mechanism is disrupted by stress. Chronic stress, while increasing circulating ghrelin, simultaneously promoted a profound loss of ghrelin binding sites in the amygdala. This induced a state of behavioral insensitivity to ghrelin receptor agonism.
This central ghrelin resistance provides a novel link between stress and vulnerability to excessive fear memory formation, explaining how high ghrelin levels can coexist with heightened fear in stressed individuals.
Key Findings
- In unstressed rats, higher endogenous ghrelin after fear learning correlates with weaker long-term fear memory.
- Pharmacological agonism of the ghrelin receptor during consolidation reduces fear memory strength in unstressed animals.
- Chronic stress promotes a 'profound loss' of ghrelin binding sites specifically in the amygdala.
- Chronic stress induces behavioral insensitivity to ghrelin receptor agonism, creating central ghrelin resistance.
- Endogenous ghrelin accounts for 'virtually all' interindividual variability in long-term fear memory in unstressed rats.
Why It Matters
This research reframes ghrelin's role in mental health, suggesting its fear-reducing effects are conditional and depend entirely on stress history. For individuals using ghrelin secretagogues like MK-677, this implies that the compound's potential anxiolytic or fear-dampening benefits might be completely nullified or absent in the presence of chronic stress due to receptor downregulation in the amygdala. The study reveals a critical state-dependent mechanism: ghrelin's emotional regulation works in unstressed states but fails during chronic stress, potentially exacerbating fear-related pathologies. This suggests that restoring ghrelin sensitivity in the brain, rather than simply increasing ghrelin levels, could be a more effective therapeutic strategy for stress-induced anxiety disorders. The findings are preclinical and direct human translation requires further investigation into amygdalar ghrelin resistance.
ghrelin
mk-677
fear memory
chronic stress
ptsd
anxiety
